On-Demand Webcast

Share

Program Content

Activities

  • HER2-Targeted Therapy for NSCLC
    Improving Outcomes for Patients With Advanced NSCLC Through the Optimal Integration of HER2-Targeted Antibody–Drug Conjugate Therapy
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2023

    Expires: November 30, 2024

Faculty

cover img faculity

Nisha Mohindra, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Feinberg School of Medicine of Northwestern University
Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.